Doprava zadarmo od 24,99 €. Viac info.
Bookbot

Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors

The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline

Parametre

  • 168 stránok
  • 6 hodin čítania

Viac o knihe

With a minimum of side effects, low toxicity in overdose and a broad range of clinical applications, selective serotonin re-uptake inhibitors have found widespread and increasing use in psychiatry worldwide. Here is the most comprehensive reference source available on these important drugs. Beginning with examinations of the drugs' pharmacology their effects on serotonergic function and the central role of serotonin in many psychiatric disorders, the book moves on to reviews of clinical trials in many psychiatric conditions. Finally, an important chapter discusses clinical issues in the use of these agents.

Nákup knihy

Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors, John Preston Feighner, W. F. Boyer

Jazyk
Rok vydania
1991
Väzba
(pevná)
Akonáhle sa objaví, pošleme e-mail.

Doručenie

  • Doprava zadarma od 24,99 € po celom Slovensku! Viac info

Platobné metódy

Nikto zatiaľ neohodnotil.Ohodnotiť

Titul
Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors
Podtitul
The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline
Jazyk
anglicky
Vydavateľ
WILEY
Rok vydania
1991
Väzba
pevná
Počet strán
168
ISBN10
0471928909
ISBN13
9780471928904
Série
Anotácia
With a minimum of side effects, low toxicity in overdose and a broad range of clinical applications, selective serotonin re-uptake inhibitors have found widespread and increasing use in psychiatry worldwide. Here is the most comprehensive reference source available on these important drugs. Beginning with examinations of the drugs' pharmacology their effects on serotonergic function and the central role of serotonin in many psychiatric disorders, the book moves on to reviews of clinical trials in many psychiatric conditions. Finally, an important chapter discusses clinical issues in the use of these agents.